In fiscal year 2025, Y-Biologics (338840) reported revenue of 2.9 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 2.9 billion KRW | -9.3 billion KRW | -42.0 billion KRW | [source] |
| 2024 | 5.8 billion KRW | -8.4 billion KRW | -6.4 billion KRW | [source] |
| 2023 | 3.5 billion KRW | -10.1 billion KRW | -20.9 billion KRW | [source] |
| 2022 | 4.2 billion KRW | -18.8 billion KRW | -18.8 billion KRW | — |
| 2021 | 4.8 billion KRW | -17.4 billion KRW | -17.1 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 55.8 billion KRW | 29.2 billion KRW | 26.6 billion KRW | [source] |
| 2024 | 21.7 billion KRW | 3.4 billion KRW | 18.4 billion KRW | [source] |
| 2023 | 30.3 billion KRW | 6.9 billion KRW | 23.4 billion KRW | [source] |
| 2022 | — | — | — | — |
| 2021 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.